Methylene Blue: The 150-Year-Old Drug Now Sold as a Longevity Hack

A blue dye older than aspirin is trending as a "brain" and "longevity" supplement — sometimes in droplet bottles sold off a phone screen. NU lays down the real medical record, the trend, and the documented risks. Commentary on the public record. This is not medical advice.

1. The part people feel first

Someone scrolling at 1 a.m. sees a wellness influencer drip a vivid blue liquid under their tongue and say it "powers your mitochondria," sharpens focus, and slows aging. It looks futuristic. It is, in fact, one of the oldest synthetic drugs still in human use — and the same chemistry that makes it useful in a hospital is what makes the casual version risky. The honest move is to separate the trend from the record.

2. The documented history (this part is not disputed)

Methylene blue (methylthioninium chloride) was first synthesized in 1876 by German chemist Heinrich Caro at BASF as a textile dye【Britannica】. Within years it became a workhorse of biology — Paul Ehrlich used it to stain nerve tissue and, in 1891, reported it as a treatment for malaria, making it arguably the first fully synthetic drug used in humans【Schirmer et al., Redox Report】.

Its enduring medical role is narrow and real: methylene blue is an FDA-approved treatment for methemoglobinemia — a condition where blood can't release oxygen properly — given as a controlled intravenous dose under medical supervision【FDA prescribing information, accessdata.fda.gov】. It is also used as a surgical dye and was historically used for urinary tract antiseptic purposes. That is the legitimate record: a century-plus-old, well-characterized prescription drug, not a daily supplement.

3. What the trend claims

The current wellness pitch leans on real laboratory observations and then stretches them. In cell and animal studies, low-dose methylene blue can act on the mitochondrial electron transport chain and has antioxidant behavior, which is the basis for "cellular energy" marketing【Tucker et al., review in Antioxidants】. Small studies have explored it for memory and as an experimental agent in neurodegenerative disease.

But state it plainly: the FDA has not approved methylene blue for memory, focus, "longevity," depression, or general wellness. Human evidence for those uses is preliminary or absent, and the leap from a petri dish to a sublingual dropper marketed online is not supported by the clinical record. "Promising in the lab" is not "proven in people." Kooky till proven — and this one is not proven for the trendy uses.

4. The real risks (the cautionary core)

Serotonin syndrome is the headline danger. Methylene blue is a potent inhibitor of monoamine oxidase A (MAO-A) — the same enzyme blocked by MAOI antidepressants. On July 26, 2011, the FDA issued a Drug Safety Communication warning that methylene blue can cause potentially fatal serotonin syndrome when combined with serotonergic drugs — SSRIs, SNRIs, tricyclics, MAOIs, triptans, tramadol, and meperidine【FDA Drug Safety Communication, 2011; current FDA labeling】. Symptoms include agitation, confusion, rapid heart rate, muscle twitching, sweating, high fever, and in severe cases death.

This matters enormously for the supplement crowd: a large share of adults take antidepressants. Someone self-dosing blue drops they bought online — without telling a doctor, without knowing the interaction — is exactly the scenario the FDA warned against.

Other documented hazards:

• Dose matters and "more" is dangerous. At higher doses methylene blue flips from antioxidant to pro-oxidant and, paradoxically, can cause methemoglobinemia and hemolysis【Drugs.com monograph; FDA labeling】.
• G6PD deficiency. People with this common enzyme deficiency can suffer dangerous red-blood-cell breakdown; methylene blue is contraindicated or used with extreme caution【FDA labeling】.
• Pregnancy. Linked to fetal harm; not recommended【FDA labeling】.
• Unregulated product quality. "Pharmaceutical grade" claims on consumer dropper bottles are not the same as a verified pharmacy product; industrial/aquarium-grade methylene blue can contain heavy-metal impurities and is not for human consumption.

And the visible-but-harmless part: it turns urine, and sometimes the tongue and skin, blue-green. That's the cosmetic effect. The serotonin interaction is the one that lands people in the ER.

5. The record, side by side

• Claim: "Safe, natural energy and longevity booster."
• Record: A 150-year-old prescription drug with a specific approved use (methemoglobinemia), a black-box-level interaction warning from the FDA, and no FDA approval for the trendy uses.

Both can be true at once: methylene blue is genuinely useful medicine and a genuinely risky thing to drip into your mouth on influencer advice — especially if you take antidepressants. NU's position is the boring, honest one: this is a real drug, treat it like one.

6. Note on imagery

The photograph used with this article is a real image of a methylene blue sample, from Wikimedia Commons — Methylene blue sample.jpg by Adam Rędzikowski, licensed CC BY-SA 3.0. It shows the actual substance, not a stock graphic.

This is not medical advice. Talk to a physician or pharmacist before taking methylene blue — especially if you take any antidepressant or psychiatric medication. Sources cited inline: U.S. FDA prescribing information and the 2011 FDA Drug Safety Communication, Drugs.com professional monograph, Encyclopaedia Britannica, and peer-reviewed reviews (Schirmer et al., Tucker et al.). Where human evidence is preliminary, that is stated as such.